UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of
Report (Date of earliest event reported) August 9, 2010
|
VALIANT
HEALTH CARE, INC.
|
||
|
(Exact
name of registrant as specified in its charter)
|
||
|
|
||
|
Florida
|
000-53496
|
26-0655541
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
210
N. University Drive, Suite 810, Coral Springs, Florida
|
33071
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
| Registrant's telephone number, including area code |
(954)
755-5564
|
|
|
Willing
Holding, Inc.
21218
St. Andrews Blvd., #131, Boca Raton, FL 33432
|
||
|
(Former
name or former address, if changed since last
report)
|
||
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.):
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.02 – Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As of
August 9, 2010, which was 10 business days after the mailing of the Company’s
Schedule 14f-1 to its shareholders, the following individuals were appointed
members of Valiant’s Board of Directors: Mirella
Salem, Boris Bergus, Marc Love, John J. McAteer and Barry I.
Rubin. These individuals join Aarif Dohad and Thomas L. DiStefano III
on the Board.
There are
no arrangements or understandings between the Company and any other persons,
pursuant to which these persons were selected as a director.
Item 8.01 – Other
Information
As
of July 23, 2010, the Company legally changed its name with a filing
with the Florida Secretary of State to “Valiant Health Care,
Inc.” In addition, as of August 10, 2010, this name change was
made effective with FINRA through a corporate action filed with them and the
Company’s trading symbol was changed as of that date to “VHCI”.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Current
Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly
authorized.
| VALIANT HEALTH CARE, INC. | |||
|
|
By:
|
/s/ Mirella Salem | |
| Name: Mirella Salem | |||
| Title: Chief Executive Officer | |||
Dated:
August 11, 2010
2